Here, we discuss the current status and future prospects of treatment strategies for pemphigus, focusing mainly on rituximab and Bruton's tyrosine kinase (BTK) inhibitors, which are expected to become essential in the future treatment of this disease. The gene discussed is BTK; the disease is pemphigus.